Navigation Links
Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI)
Date:1/24/2011

loped as a treatment for infectious diarrhea.

Additional information can be found at http://www.optimerpharma.com.

Forward Looking StatementsStatements included in this press release that are not a description of historical facts are forward-looking statements, including without limitation all statements related to the FDA's review of Optimer's NDA, including any advisory committee meetings, potential approval and commercial launch of fidaxomicin, and the incidence of CDI. Words such as "believes," "anticipates," "plans," "expects," "intend," "will," "goal" and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by Optimer that any of its plans will be achieved. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in Optimer's business including, without limitation, risks relating to: the timing, progress and likelihood of success of its product development efforts, the timing and status of regulatory filings, the timing and receipt of regulatory actions or approvals, Optimer's ability to successfully commercialize fidaxomicin, if approved, the development of alternative treatments for CDI, and other risks detailed in Optimer's filings with the Securities and Exchange Commission.ContactsOptimer Pharmaceuticals, Inc.Christina Donaghy, Corporate Communications ManagerJohn D. Prunty, Chief Financial Officer & VP Finance858-909-0736Canale Communications, Inc.Jason I. Spark, Senior Vice President619-849-6005
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
8. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
10. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
11. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Texas , July 30, 2015 /PRNewswire/ ... company focused on gynecologic disease, announced today ... financial results after the market close on ... investor conference call and webcast at 4:30pm ... 13, 2015 at 4:30pm Eastern/1:30pm Pacific  ...
(Date:7/30/2015)... , July 30, 2015  NanoSmart Pharmaceuticals, Inc., ... platforms, has received Orphan Drug Designation from the ... drug product that uses NanoSmart,s proprietary drug delivery ... dactinomycin for the treatment of Ewing,s sarcoma, a ... granted NanoSmart,s Orphan Drug Designation on the basis ...
(Date:7/30/2015)... Flexpoint Ford, a private equity firm focused ... that it has entered into a partnership with ... form Kastle Therapeutics, LLC (Kastle).  The new company, headquartered ... acquiring, developing and commercializing pharmaceuticals targeted toward diseases with ... therapies already approved for marketing, as well as clinical ...
Breaking Medicine Technology:NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3
... the world,s only amputee professional kiteboarder and waverider, will be ... Thursday, Jan. 6 on the Discovery Channel,s HD Theater. All ... 17th. Using the Renegade prosthetic foot from Freedom ... the wind as it whistles through the most rugged terrain ...
... 2011 BioDrain Medical, Inc. (OTC Bulletin Board: BIOR ... surgical fluid disposal, announced today it is eligible for trading ... The company was admitted to the OTCBB early in 2010 ... market maker going out of business.  For the last several ...
Cached Medicine Technology:Discovery Channel to Feature World's Only Amputee Kiteboarder 2BioDrain Medical, Inc. Is Eligible for Trading on the OTCBB, Notice of Allowance on Canadian Patent Application 2
(Date:7/30/2015)... ... July 30, 2015 , ... World ... am Fine, an app invention that can help people during emergencies. , "The ... Cooper, CEO and Creative Director of World Patent Marketing. "Currently, there are about ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... OSF ... to results from the 2015 Most Wired Survey conducted by Hospitals & Health Networks. ... health system owned and operated by The Sisters of the Third Order of ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... entitled " Lovetraction Lines ." It's for women interested in improving their love ... desire. The course, which officially launched to the public early this morning, has ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... worked to protect victims in San Diego, California’s Gaslamp Quarter Plaza for five ... Gaslamp Quarter Plaza actively monitor the area for any suspicious activity. These cameras ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Google recently ... an upcoming dedicated web site. As discussed in a June 8, 2015 article published ... collisions reported so far have been caused by its computer-driven cars, which such industry ...
Breaking Medicine News(10 mins):Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3Health News:Lovetraction Lines - Review Examining Simone Myers' New Online Course Released 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3
... who bring them pebbles to build egg nests. Hummingbirds ... guarded by larger males. , New research shows ... will still attempt to trade sexual currency for provisions, ... Michigan School of Public Health. , The exchange of ...
... Men with serious injuries, such as traumatic brain injury or ... If these men have strong traditional masculine ideas and abuse ... and come to terms with their emotions and situations. A ... find better ways to understand and treat men who fit ...
... clinical trials could start in several years, study says , , ... inhibits the formation of scar tissue at the site of ... regenerate has been developed by researchers at Northwestern University in ... ability to regrow after a spinal injury, but they,re blocked ...
... extend safety practices, CDC reports , , THURSDAY, April 10 ... of foodborne illnesses have remained constant in the United ... And that leveling off of the rate of food ... Control and Prevention,s goal of reducing the overall number ...
... cancer-killing activities in cultured cells. While they are ... trials, just how they execute their effects is ... papers, Vanderbilt-Ingram Cancer Center investigators provide a potential ... cells and offer clues about possible adverse effects ...
... PHILADELPHIA, April 10 SAGES 2008 ANNUAL ... a new study showing,laparoscopic surgery reduced the ... when compared to open surgery in a ... of the following three surgical,procedures: hysterectomy, cholecystectomy ...
Cached Medicine News:Health News:Just like penguins and other primates, people trade sex for resources 2Health News:Triple threat: Young macho men with serious injuries often abuse alcohol 2Health News:Gel Enables Severed Spinal Cord Fibers to Regrow 2Health News:Foodborne Illnesses Remain Constant in U.S. 2Health News:Foodborne Illnesses Remain Constant in U.S. 3Health News:The good and bad side of anti-cancer compounds 2Health News:The good and bad side of anti-cancer compounds 3Health News:Study Showed Minimally Invasive Surgery Reduced Risk of Hospital-Acquired Infections Compared to Open Surgery 2Health News:Study Showed Minimally Invasive Surgery Reduced Risk of Hospital-Acquired Infections Compared to Open Surgery 3
... Bard Collagen Implant, the world's leading bulking ... for the treatment of Stress Urinary Incontinence ... surrounding urethral tissue to aid coaptation in ... body's own structure, Contigen Bard Collagen Implant ...
... Titan™ Inflatable Penile Prosthesis (IPP) ... to be surgically implanted into ... of erectile dysfunction (also known ... the patient with voluntary control ...
... The AMS 650™ and 600M™ malleable ... many patientsespecially those with limited dexterity. These ... allows the patient to position them in ... make the penis rigid enough for sexual ...
... continues to be a proven, reliable penile ... to have mechanical reliability rates of over ... ioflex material contributes to excellent mechanical reliability ... Bioflex: ,Provides maximum, controlled girth expansion to ...
Medicine Products: